Medical Treatment Strategies for Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is a heterogeneous genetic heart disease inherited in an autosomal dominant pattern with an estimated ...

Hypertrophic cardiomyopathy - Diagnosis and treatment - Mayo Clinic

Cardiac resynchronization therapy (CRT) device. Rarely, this implanted device is used as a treatment for hypertrophic cardiomyopathy. It can ...

Pathophysiology and Implications for Management. Hypertrophic cardiomyopathy (HCM) is a genetic heart disease inherited in an autosomal dominant ...

Medical Treatment Strategies for Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is a heterogeneous genetic heart disease inherited in an autosomal dominant pattern with an estimated prevalence of 0.6% ...

Management of Hypertrophic Cardiomyopathy: JACC State-of-the ...

Hypertrophic cardiomyopathy (HCM), a relatively common, globally distributed, and often inherited primary cardiac disease, has now transformed ...

Hypertrophic Cardiomyopathy Treatment & Management

Sudden cardiac death occurs in approximately 1% of patients with hypertrophic cardiomyopathy (HCM) each year, and pharmacotherapy has not shown ...

Treatment Strategies for Hypertrophic Cardiomyopathy: Surgical

Septal myectomy is a well-established procedure for septal reduction in patients with obstructive hypertrophic cardiomyopathy (HCM) who have not responded to ...

Treatment of Hypertrophic Cardiomyopathy: What Every Cardiologist ...

Hypertrophic cardiomyopathy (HCM) is an inherited disease of the cardiac sarcomere that results in left ventricular hypertrophy, ...

An overview of the treatments for hypertrophic cardiomyopathy

PTSMA has emerged as the best substitute to septal myectomy for decreasing HCM outflow gradients and improving heart failure symptoms (73, 74).

Pharmacological Management of Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM), the most common inherited heart disease, is still orphan of a specific drug treatment. The erroneous consideration of HCM ...

2020 AHA/ACC Guideline for the Diagnosis and Treatment of ...

Optimal care for patients with HCM requires cardiac imaging to confirm the diagnosis, characterize the pathophysiology for the individual, and ...

Hypertrophic Cardiomyopathy (HCM) - American Heart Association

Treatment and management of HCM. There is currently only one disease-specific medication to treat hypertrophic cardiomyopathy. Mavacamten is ...

Pharmacological treatment options for hypertrophic cardiomyopathy

Abstract. Hypertrophic cardiomyopathy (HCM) is the most common genetic heart disease, affecting over one million individuals in Europe.

Medical treatment of patients with hypertrophic cardiomyopathy

Management of symptoms in patients with non-obstructive hypertrophic cardiomyopathy (NO-HCM). CRT: cardiac resynchronization therapy; ICD: implantable ...

Diagnosis and Management of Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, the most common genetic cardiac disease, is present in 1 out of 500 individuals regardless of race or gender.

Old and new therapeutic solutions in the treatment of hypertrophic ...

Abstract. Hypertrophic cardiomyopathy (HCM) is a genetic disease of the myocardium that is relatively common in the general population, ...

Evolving Strategies for the Management of Obstructive Hypertrophic ...

For many years, treatment of hypertrophic cardiomyopathy (HCM) has focused on non-disease-specific therapies. Cardiac myosin modulators (ie, mavacamten and ...

Medication for Hypertrophic Cardiomyopathy - NYU Langone Health

NYU Langone doctors may prescribe medication to manage the symptoms of hypertrophic cardiomyopathy (HCM). In this condition, the walls of the heart's lower ...

Exercise, New Drug Class Recommended for Management of ...

Updated recommendations in the guideline reflect recent evidence about HCM treatment and management including new forms of pharmacologic ...

New treatment strategies for hypertrophic obstructive cardiomyopathy

Figure 1. ... Figure 1. Treatment strategy in hypertrophic cardiomyopathy (HCM). ICD = implantable cardioverter-defibrillator; NSVT = nonsustained ventricular ...